This week on “The Top Line,” we explore peripheral arterial disease, a serious health issue that is often overlooked and undermanaged.
Join Editor-in-Chief of Fierce Life Sciences and Healthcare Ayla Ellison as she sits down with Kumar Madassery, M.D., Director of the Peripheral Vascular Intervention & CLI Program at Rush University Medical Center. They discuss the hidden dangers of PAD, and Dr. Madassery emphasizes the importance of early detection. He also discusses the launch of the PAD Pulse Alliance, a collaborative effort among vascular health experts aimed at raising awareness, improving early detection and reducing amputation rates.
To learn more about the topics in this episode:

FDA Breakthrough Therapy and RMAT: Strategic Decisions That Can Accelerate Oncology Development (Sponsored)
20:26

Ipsen R&D chief on pipeline discipline, partnerships and 2026 milestones
15:08

Why MRD is becoming central to oncology drug development (Sponsored)
18:38